Lung Cancer News

• Blood Test to Identify Individuals for Lung Cancer Screening A simple biomarker test shows promise for refining the eligibility criteria for lung cancer screening, identifying more high-risk individuals for low-dose CT and reducing false positives.
  Medscape Medical News, July 2018
• Proton Therapy Trials 'at Risk,' Slow to Enroll Patients Is proton therapy better than standard radiotherapy in the treatment of cancer? Seven major randomized clinical trials have no answers at this point.
  Medscape Medical News, July 2018
• Geriatric Assessments Could Fine-Tune Cancer Care for Older Adults The American Society of Clinical Oncology issued a new guideline that recommends adults 65 and older receive a geriatric assessment when considering or undergoing chemotherapy.
  Kaiser Health News, July 2018
• ASCO 2018'Cancer Is Almost Always a Crisis' Cancer patients are particularly vulnerable to psychosocial distress as a result of both the diagnosis and treatment, which can affect treatment decisions. But how can this burden best be tackled?
  Medscape Medical News, July 2018
• AstraZeneca Wins Speedy Approvals for Cancer Drugs in Japan AstraZeneca has won rapid regulatory approval for new uses of two of its important cancer drugs in Japan, less than six months after the first global approvals in Western markets.
  Reuters Health Information, July 2018
• Tokyo Passes Tough Anti-Smoking Law Ahead of 2020 Olympics Tokyo, Japan's capital and host of the 2020 Summer Olympics, passed a tough anti-smoking law on Wednesday that will effectively ban smoking in most of the city's bars and restaurants in the run-up to the games.
  Reuters Health Information, June 2018
• WCGC 2018Explosion in GI Cancer Drugs 'Confusing for Clinicians' Clinicians have a confusing picture of which drugs to choose for gastrointestinal cancers, owing to the way trials are designed, although help is at hand from clinical assessment tools, argue experts.
  Medscape Medical News, June 2018
• Study Preserves Hopes for Roche's Tecentriq in Lung Cancer Swiss drugmaker Roche's hopes of having the first immunotherapy cocktail to be approved as an initial treatment for an aggressive form of lung cancer remained intact on Monday after a trial showed positive survival data.
  Reuters Health Information, June 2018
• Pro-Smoking Japanese Lawmaker Apologizes for Heckling Cancer Patient A Japanese member of parliament apologized on Thursday for jeering a lung cancer patient testifying about the dangers of secondhand smoke, saying he had spoken out to prevent discrimination against smokers.
  Reuters Health Information, June 2018
• ASCO 2018'Revolutionary': Some Oligometastatic Cancers Are Curable Metastatic cancer has long been considered incurable. The concept of oligometastatic cancer challenges and changes that in a broad way.
  Medscape Medical News, June 2018
• Cancer Burden on the Rise in Much of the World The global cancer burden is rising, but some of that increase is in potentially preventable cancers that lifestyle interventions could reduce.
  Medscape Medical News, June 2018
• Atezolizumab Increases Progression-free Survival in Lung Cancer Patients – Study Adding atezolizumab to a combination of bevacizumab, carboplatin and paclitaxel gives patients with metastatic nonsquamous non-small-cell lung cancer better odds of progression-free and overall survival, a new study of 692 patients with wild-type disease has concluded.
  Reuters Health Information, June 2018
• ASCO 2018Merck's Keytruda Extends Lung Cancer Survival in Two Trials Merck & Co's immunotherapy Keytruda improved survival as a stand-alone treatment for newly-diagnosed lung cancer patients and with chemotherapy for hard-to-treat squamous cell lung cancer, new data released on Sunday showed, further cementing the company's lead in the most lucrative oncology market.
  Reuters Health Information, June 2018
• 'End of an Era' for Chemo in Non-Small Cell Lung Cancer The fear of unsupportable adverse effects from chemotherapy can be laid to rest for most patients with non-small cell lung cancer, say experts at the world's largest cancer meeting.
  Medscape Medical News, June 2018
• ASCO 2018Detecting Lung Cancer From Simple Blood Draw Two years ago it was a 'pipe dream', but a new study show that a simple blood test for circulating tumor DNA can detect lung cancer; the dream inches ever closer to becoming a reality.
  Medscape Medical News, June 2018
• ASCO 2018ASCO President Talks of 'New Understanding' After Own Cancer In his presidential address, Dr Bruce Johnson described the 'new understanding' he has for patients after his own cancer diagnosis.
  Medscape Medical News, June 2018
• Lung Cancer Risk Drops Within 5 Years of Quitting Smoking A good news, bad news story for smokers: The risk for lung cancer drops within 5 years of quitting smoking, yet that risk remains elevated for many decades to come.
  Medscape Medical News, June 2018
• HIV-Infected Pts May Benefit Similarly From Lung Cancer Screening HIV patients who undergo lung cancer screening would have reductions in mortality similar to those seen in people without HIV, according to a simulation study.
  Reuters Health Information, May 2018
• ASCO 2018Merck's Keytruda Boosts Response in Hard-to-Treat Lung Cancer The combination of Merck & Co's immunotherapy Keytruda and chemotherapy boosted response rates in patients with advanced hard-to-treat squamous cell lung cancer, the company said.
  Reuters Health Information, May 2018
• ASCO 2018Merck KGaA's Lung Cancer Drugs Show Promise in Early-Stage Trials Germany's Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain lung cancer patients, potentially helping efforts to find a drug-industry partner to share further development costs for one of them.
  Reuters Health Information, May 2018